Illustrative pack image. Actual packaging may differ.
RIBZVAL-DSR Tablet
Advanced Relief from Acidity & Gastric Discomfort
Composition
Rabeprazole Sodium 20 mg + Domperidone 30 mg SR
- Prescription medicine
- Available to order
Overview
RIBZVAL-DSR is a dual-action, sustained-release formulation that combines a proton pump inhibitor (Rabeprazole 20 mg) with a prokinetic agent (Domperidone 30 mg) to effectively manage acid reflux, GERD, and related gastric conditions.
Key Benefits
- Rabeprazole: Suppresses gastric acid secretion, offering rapid and long-lasting relief from acidity and heartburn.
- Domperidone SR: Enhances gastrointestinal motility and prevents nausea, bloating, and reflux symptoms.
- Sustained Release: Ensures prolonged action and symptom control throughout the day.
Indications
- Gastroesophageal Reflux Disease (GERD)
- Acid reflux and heartburn
- Functional dyspepsia
- Nausea and bloating related to delayed gastric emptying
